Stay updated on Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe site's footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check19 days agoChange DetectedA site-wide notice explains that NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during a terminology transition and links to related updates.SummaryDifference0.3%

- Check26 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check33 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check54 days agoChange DetectedA new revision tag 'Revision: v3.7.0' was added to the history. The previous tag 'Revision: v3.6.6' appears to be removed as the latest entry.SummaryDifference0.0%

- Check75 days agoChange DetectedThe Record History now lists a new site revision, v3.6.6, as the latest update, replacing the previous v3.6.5.SummaryDifference0.0%

Stay in the know with updates to Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.